American Healthcare REIT (AHR) Soars 1.08% on Bullish Analyst Ratings

American Healthcare (AHR) shares surged to a record high today, with an intraday gain of 1.08%. The stock has been on a winning streak, rising for two consecutive days, with a total increase of 1.58% over the past two days.

The strategy of buying American Healthcare REIT (AHR) shares after they reached a recent high and holding for one week delivered substantial gains over the past five years. The strategy achieved an overall return of 150.18%, significantly outperforming the benchmark return of 19.63%. The excess return generated by the strategy was 130.56%, indicating that it delivered substantial gains relative to the benchmark. Moreover, the strategy's CAGR was 99.34%, which is a robust indicator of its compounding effectiveness.

Morgan Stanley has increased their price target for American Healthcare REIT (AHR) from $37.00 to $45.00, assigning the stock an "overweight" rating. This adjustment suggests a positive outlook and potential for further stock price increase.

BofA Securities has maintained a buy rating for AHR and significantly adjusted the target price from $16 to $41, indicating strong confidence in the stock's future performance. This move reflects the firm's optimism about the company's prospects.

Robert W. Baird has initiated coverage of AHR with an "outperform" rating and set a target price of $41.00. This rating reflects optimism about the stock's potential and aligns with the positive sentiment from other analysts.

A buy signal was issued for AHR on July 8, 2025, from a pivot bottom point, and the stock has risen by 5.97% since then. This technical indicator suggests further rise until a new top pivot is reached, adding to the bullish outlook for the stock.

Ten research analysts have given AHR a buy rating, and one has assigned a strong buy rating. This consensus of positive sentiment towards the stock further supports the optimistic outlook for American Healthcare REIT's performance in the near future.